Johnson & Johnson has clinched an FDA approval for Caplyta in depression, satisfying a major driver for its $14.6bn takeover of ICT this year.

For three decades, doctors went to UpToDate as a search tool. But as OpenEvidence, a startup building an AI-powered version, became one of the hottest

Today, healthcare isn’t what’s driving Oura’s business — technically. The revenue Oura receives from contracts with health plans and providers is “de minimis” right now,

Eli Lilly has raised the stakes in the obesity market with positive midstage data for its amylin-targeting drug eloralintide.

Moderna posted $1 billion in third-quarter revenue, down 45% from the same period a year ago, as shrinking vaccine uptake and a continued inability to